Luteolin Suppresses Sepsis-Induced Cold-Inducible Rna-Binding Protein Production and Lung Injury in Neonatal MICE.

Neonatal sepsis is a life-threatening inflammatory condition. Extracellular cold-inducible RNA-binding protein (CIRP), a proinflammatory mediator, plays a critical role in the pathogenesis of sepsis-induced lung injury in neonates. Luteolin, a polyphenolic flavonoid, has potent anti-inflammatory properties. However, the effects of luteolin on CIRP production and neonatal sepsis-induced lung injury remained unknown. We therefore hypothesize that treatment with luteolin suppresses CIRP production and attenuates lung injury in neonatal sepsis. To study this, sepsis was induced in C57BL/6J mouse pups (5-7 days) by intraperitoneal cecal slurry injection (CSI). One hour after CSI, luteolin (10 mg/kg BW) or vehicle (normal saline) were administered through intraperitoneal injection. CIRP mRNA and protein were determined and lung injury were assessed at 10 hours after CSI. Our results showed that administration of luteolin decreased CIRP mRNA and protein, improved lung architecture, reduced lung edema and apoptosis after CSI. To examine the direct effect of luteolin on CIRP production, peritoneal macrophages were isolated from neonatal mice and stimulated with 100 ng/ml LPS with or without the presence of luteolin. The result indicates that luteolin directly inhibited LPS-induced CIRP production in neonatal macrophages. In addition, luteolin also downregulated HIF-1α and NLRP3 expression in septic neonates and in LPS-stimulated neonatal macrophages. In conclusion:, administration of luteolin suppresses CIRP production and attenuates lung injury in neonatal sepsis. The beneficial effect of luteolin may be related to downregulation of HIF-1α and NLRP3 expression in neonatal macrophages. Luteolin may be developed as an adjunctive therapy for neonatal sepsis.

[1]  Xiao-hong Liu,et al.  A network pharmacology-based strategy for predicting anti-inflammatory targets of ephedra in treating asthma. , 2020, International immunopharmacology.

[2]  Hung-Rong Yen,et al.  Luteolin Attenuates Allergic Nasal Inflammation via Inhibition of Interleukin-4 in an Allergic Rhinitis Mouse Model and Peripheral Blood From Human Subjects With Allergic Rhinitis , 2020, Frontiers in Pharmacology.

[3]  Jian-chun Luo,et al.  Luteolin attenuates sepsis-induced myocardial injury by enhancing autophagy in mice , 2020, International journal of molecular medicine.

[4]  S. Jang,et al.  Effect of Luteolin and Apigenin on the Production of Il-31 and Il-33 in Lipopolysaccharides-Activated Microglia Cells and Their Mechanism of Action , 2020, Nutrients.

[5]  F. Petronilho,et al.  The NLRP3 Inflammasome and Its Role in Sepsis Development , 2019, Inflammation.

[6]  Y. Ying,et al.  Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated In fl ammatory Response , 2019 .

[7]  Shuxia Wang,et al.  Luteolin Alters Macrophage Polarization to Inhibit Inflammation , 2019, Inflammation.

[8]  Weng-Lang Yang,et al.  C23, an oligopeptide derived from cold-inducible RNA-binding protein, suppresses inflammation and reduces lung injury in neonatal sepsis. , 2019, Journal of pediatric surgery.

[9]  Rongqian Wu,et al.  Low serum irisin concentration is associated with poor outcomes in patients with acute pancreatitis and irisin administration protects against experimental acute pancreatitis. , 2019, Antioxidants & redox signaling.

[10]  Ping Wang,et al.  Extracellular CIRP (eCIRP) and inflammation , 2019, Journal of leukocyte biology.

[11]  P. Parrilla,et al.  P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis , 2019, Nature Communications.

[12]  Guan-zhong Wu,et al.  Luteolin attenuates high glucose‐induced podocyte injury via suppressing NLRP3 inflammasome pathway , 2019, Life sciences.

[13]  Rongqian Wu,et al.  Natural killer T cell ligand alpha‐galactosylceramide protects against gut ischemia reperfusion‐induced organ injury in mice , 2018, Cytokine.

[14]  Rongqian Wu,et al.  Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress , 2018, Redox biology.

[15]  J. Cho,et al.  Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. , 2018, Journal of ethnopharmacology.

[16]  Minmin Wu,et al.  Luteolin inhibits angiogenesis of the M2‑like TAMs via the downregulation of hypoxia inducible factor‑1α and the STAT3 signalling pathway under hypoxia. , 2018, Molecular medicine reports.

[17]  E. Park,et al.  Luteolin activates ERK1/2- and Ca2+-dependent HO-1 induction that reduces LPS-induced HMGB1, iNOS/NO, and COX-2 expression in RAW264.7 cells and mitigates acute lung injury of endotoxin mice , 2018, Inflammation Research.

[18]  N. Kissoon,et al.  The global burden of paediatric and neonatal sepsis: a systematic review. , 2018, The Lancet. Respiratory medicine.

[19]  Weng-Lang Yang,et al.  Deficiency in cold‐inducible RNA‐binding protein attenuates acute respiratory distress syndrome induced by intestinal ischemia‐reperfusion , 2017, Surgery.

[20]  Ashagre Molla,et al.  Clinical outcome and risk factors of neonatal sepsis among neonates in Felege Hiwot referral Hospital, Bahir Dar, Amhara Regional State, North West Ethiopia 2016: a retrospective chart review , 2017, BMC Research Notes.

[21]  N. Gupta,et al.  Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia , 2017, Proceedings of the National Academy of Sciences.

[22]  Hongwei Wang,et al.  Anti-inflammatory effects of luteolin on experimental autoimmune thyroiditis in mice. , 2016, Experimental and therapeutic medicine.

[23]  Weng-Lang Yang,et al.  Deficiency of cold-inducible ribonucleic acid-binding protein reduces renal injury after ischemia-reperfusion. , 2016, Surgery.

[24]  Jie Fan,et al.  Cold-inducible RNA-binding protein causes endothelial dysfunction via activation of Nlrp3 inflammasome , 2016, Scientific Reports.

[25]  K. Kanai,et al.  Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats , 2016, The Journal of veterinary medical science.

[26]  K. Kanai,et al.  Luteolin attenuates endotoxin-induced uveitis in Lewis rats , 2016, The Journal of veterinary medical science.

[27]  K. Tracey,et al.  Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis , 2013, Nature Medicine.

[28]  E. So,et al.  Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. , 2011, British journal of anaesthesia.

[29]  G. Haskó,et al.  HIF-1: a key mediator in hypoxia. , 2009, Acta physiologica Hungarica.

[30]  V. Nizet,et al.  Cutting Edge: Essential Role of Hypoxia Inducible Factor-1α in Development of Lipopolysaccharide-Induced Sepsis1 , 2007, The Journal of Immunology.

[31]  R. Kirschner,et al.  Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism , 2004, Journal of Cell Science.

[32]  Zhi Li,et al.  Luteolin alleviates NLRP3 inflammasome activation and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells. , 2018, American journal of translational research.